Publications List

Including Posters, Abstracts, and Presentations

For more information, or to obtain copies of articles published before 2015, email:

Brüggenjürgen, B, Andersohn, F, Burkowitz, J, Ezzat, N, Gaudig, M, Willich, SN (2016). Cohort Study on Predictors of Need for Nursing Care in Alzheimer’s Disease: An Analysis of Healthcare Data. Journal of Alzheimer’s Disease. doi: 10.3233/JAD-160137

Burkowitz J, Merzenich, C, Grassme K, Brüggenjürgen B (2016). Insertable Cardiac Monitors in the Diagnosis of Syncope and the Detection of Atrial Fibrillation: A Systematic Review and Meta-Analysis. European Journal of Preventative Cardiology. doi: 10.1177/2047487316632628

Doshi S, Ray D, Stein K, Zhang J, Koduro P, Fogt F, Wellman A, Wat R, Mathews, C (2016). Economic Analysis of Alternative Strategies for Detection of ALK Rearrangements in Non Small Cell Lung Cancer. Diagnostics. doi: 10.3390/diagnostics6010004

Sabatini L, Mathews C, Ptak D, Doshi S, Tynan K, Hedge M, Burke T, Bossler A (2016). Genomic Sequencing Procedure Microcosting Analysis and Health Economic Cost-Impact Analysis. The Journal of Molecular Diagnostics. doi: 10.1016/j.jmoldx.2015.11.010

Aggarwal J, Goss T, Mathews C, Kearney P, Diette G (2015). Budget Impact Model of a Blood Based Proteomic Classifier for Indeterminate Pulmonary Nodules. Presented at the 20th Annual ISPOR International Meeting, Philadelphia, PA, May 18, 2015.

Beaton R, Ferrara J, Rompas S (2015). Digital Health Innovation in the US Value Environment. White Paper.

Rompas S, Goss T, Amanuel S, Victoria Coutinho V, Lai Z, Antonini P, Murphy MF (2015). Demonstrating Value for Biosimilars: A Conceptual Framework. American Health & Drug Benefits. 2015 May; 8(3).

Sweeney N and Goss T (2015). The Value of Innovation in Oncology: Recognizing Emerging Benefits Over Time. White Paper: Pharmaceutical Research and Manufacturers of America (PhRMA).